T. Saeki

1.2k citations

60 papers · 1.0k indexed · h-index 19

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Treatment and Management
Organic Chemistry top 10%

Papers in ⓘ

Molecular Biology 24
- Phosphodiesterase function and regulation 7
- Peroxisome Proliferator-Activated Receptors 4
Surgery 17
- Cholesterol and Lipid Metabolism 10
- Lipoproteins and Cardiovascular Health 6

Co-authors: Isao Saito (11 shared papers)Yasutaka Takase (7 shared papers)Nobuyuki Yasuda (8 shared papers)Tadashi Nagakura (7 shared papers)Isao Tanaka (7 shared papers)Takashi Inoue (7 shared papers)Kazuto Yamazaki (7 shared papers)Kazunobu Kira (5 shared papers)
Journals: European Journal of Pharmacology (4 papers)Journal of Medicinal Chemistry (4 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)Atherosclerosis (3 papers)Synlett (2 papers)
Partner nations: Japan India United Kingdom

In The Last Decade

T. Saeki

58 papers receiving 969 citations

Peers

Countries citing papers authored by T. Saeki

Since Specialization

Citations

This map shows the geographic impact of T. Saeki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Saeki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Saeki more than expected).

Fields of papers citing papers by T. Saeki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Saeki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Saeki. The network helps show where T. Saeki may publish in the future.

Co-authors

The 25 scholars most cited alongside T. Saeki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with T. Saeki Line = papers co-authored together T. Saeki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Enhanced secretion of glucagon-like peptide 1 by biguanide compounds Biochemical and Biophysical Research Communications ·Nobuyuki Yasuda, Takashi Inoue, Tadashi Nagakura, Kazuto Yamazaki, Kazunobu Kira, T. Saeki, Isao Tanaka	2002	119
2	Cyclic GMP Phosphodiesterase Inhibitors. 2. Requirement of 6-Substitution of Quinazoline Derivatives for Potent and Selective Inhibitory Activity Journal of Medicinal Chemistry ·Yasutaka Takase, T. Saeki, Nobuatsu Watanabe, Hideyuki Adachi, Satoshi Souda, Isao Saito	1994	89
3	Trimethylsilyl Bis(trifluoromethanesulfonyl)amide as an Effective Catalyst for the Friedel-Crafts Alkylation Reaction Synlett ·Akihiro Ishii, Osamu Kotera, T. Saeki, Kōichi Mikami	1997	63
4	A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery. Journal of Pharmacology and Experimental Therapeutics ·T. Saeki, Hayamitsu Adachi, Yasutaka Takase, Shigenori Yoshitake, Satoshi Souda, Isao Saito	1995	59
5	Metformin Causes Reduction of Food Intake and Body Weight Gain and Improvement of Glucose Intolerance in Combination with Dipeptidyl Peptidase IV Inhibitor in Zucker fa/fa Rats Journal of Pharmacology and Experimental Therapeutics ·Nobuyuki Yasuda, Takashi Inoue, Tadashi Nagakura, Kazuto Yamazaki, Kazunobu Kira, T. Saeki, Isao Tanaka	2004	53
6	Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors Journal of Lipid Research ·Hironobu Hiyoshi, Mamoru Yanagimachi, Masashi Ito, Issei Ohtsuka, Ichiro Yoshida, T. Saeki, Hiroshi Tanaka	2000	53
7	Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta Biochemical Pharmacology ·T. Saeki, Isao Saito	1993	41
8	Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes Journal of Lipid Research ·Hironobu Hiyoshi, Mamoru Yanagimachi, Masashi Ito, Nobuyuki Yasuda, Toshimi Okada, Hironori Ikuta, Daisuke Shinmyo, Keigo Tanaka, Nobuyuki Kurusu, Ichiro Yoshida, Shinya Abe, T. Saeki, Hiroshi Tanaka	2003	38
9	Positron-Annihilation Study of Icosahedral AlPdMn Alloys Physical Review Letters ·I. Kanazawa, E. Hamada, T. Saeki, K. Sato, Maho Nakata, S. Takeuchi, Markus Wollgarten	1997	33
10	Lanthanide Perfluoroalkylsulfonylamide Catalysts for Fluorous Phase Organic Synthesis Synlett ·Joji Nishikido, Hitoshi Nakajima, T. Saeki, Akihiro Ishii, Koichi Mikami	1998	29
11	Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits Atherosclerosis ·Hiroshi Tanaka, Issei Ohtsuka, Motoji Kogushi, Teiji Kimura, Tohru Fujimori, T. Saeki, Kenji Hayashi, Hiroko Kobayashi, Toshie Yamada, Hironobu Hiyoshi, Isao Saito	1994	28
12	Cyclic GMP phosphodiesterase inhibitors. 1. The discovery of a novel potent inhibitor, 4-[[3,4-(methylenedioxy)benzyl]amino]-6,7,8-trimethoxyquinazoline Journal of Medicinal Chemistry ·Yasutaka Takase, T. Saeki, Masayuki Fujimoto, Isao Saito	1993	27
13	Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism European Journal of Pharmacology ·Hironobu Hiyoshi, Mamoru Yanagimachi, Masashi Ito, T. Saeki, Ichiro Yoshida, Toshimi Okada, Hironori Ikuta, Daisuke Shinmyo, Keigo Tanaka, Nobuyuki Kurusu, Hiroshi Tanaka	2001	27
14	Comparison of Efficacies of a Dipeptidyl Peptidase IV Inhibitor and α-Glucosidase Inhibitors in Oral Carbohydrate and Meal Tolerance Tests and the Effects of Their Combination in Mice Journal of Pharmacological Sciences ·Kazuto Yamazaki, Takashi Inoue, Nobuyuki Yasuda, Yoshiaki Sato, Tadashi Nagakura, Osamu Takenaka, Richard J. Clark, T. Saeki, Isao Tanaka	2007	25
15	The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight European Journal of Pharmacology ·Kazuto Yamazaki, Nobuyuki Yasuda, Takashi Inoue, Tadashi Nagakura, Kazunobu Kira, T. Saeki, Isao Tanaka	2004	23
16	Microsomal Reductase for Aromatic Aldehydes and Ketones in Guinea Pig Liver. Purification, Characterization, and Functional Relationship to Hexose-6-Phosphate Dehydrogenase1 The Journal of Biochemistry ·Hideo Sawada, Akira Hara, Msakazu HAYASHIBARA, Toshihiro Nakayama, Shigeyuki Usui, T. Saeki	1981	23
17	Structure-activity relationship of N-[2-(dimethylamino)-6-[3-(5-methyl-4-phenyl-1H-imidazol-1-yl)propoxy]phenyl]-N'-pentylurea and analogs. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with antiatherosclerotic activity Journal of Medicinal Chemistry ·Teiji Kimura, Yasutaka Takase, Kenji Hayashi, Hiroshi Tanaka, Issei Ohtsuka, T. Saeki, Motoji Kogushi, Toshie Yamada, Tohru Fujimori	1993	20
18	Mechanism of prevention by capsaicin of ethanol‐induced gastric mucosal injury – a study in the rat using intravital microscopy Alimentary Pharmacology & Therapeutics ·T. Saeki, Takashi Ohno, Katsuharu Boku, Katsunori Saigenji, Makoto Katori, Masataka Majima	2000	20
19	Measurement of chloral hydrate, trichloroethanol, trichloroacetic acid and monochloroacetic acid in the serum and the urine by gas chromatography International Archives of Occupational and Environmental Health ·Masana Ogata, T. Saeki	1974	20
20	Structure-activity relationship of a series of phenylureas linked to 4-phenylimidazole. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with antiatherosclerotic activity. 2 Journal of Medicinal Chemistry ·Teiji Kimura, Nobuhisa Watanabe, Makoto Matsui, Kenji Hayashi, Hiroshi Tanaka, Issei Ohtsuka, T. Saeki, Motoji Kogushi, Hiroko Kabayashi	1993	18

About T. Saeki

T. Saeki is a scholar working on Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine, Organic Chemistry and Endocrinology, Diabetes and Metabolism, having authored 60 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Diabetes Treatment and Management (7 papers), Phosphodiesterase function and regulation (7 papers), Lipoproteins and Cardiovascular Health (6 papers), Neuropeptides and Animal Physiology (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (238 citations), Organic Chemistry (214 citations), Molecular Biology (450 citations), Surgery (261 citations) and Pharmacology (94 citations). T. Saeki has collaborated with scholars based in Japan, India and United Kingdom. Frequent co-authors include Isao Saito, Yasutaka Takase, Nobuyuki Yasuda, Tadashi Nagakura, Isao Tanaka, Takashi Inoue, Kazuto Yamazaki, Kazunobu Kira, Akihiro Ishii and Hiroshi Tanaka. Their work appears in journals such as European Journal of Pharmacology, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, Atherosclerosis and Synlett.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact